Prostate cancer--not a benign malignancy
Totonchi, E.; Guinan, P.D.; Mouli, K.; Ordonez, C.; Shaw, M.; Ablin, R.J.
Indian Journal of Medical Research 79: 93-95
1984
ISSN/ISBN: 0019-5340 PMID: 6724658 Document Number: 221211
Consecutive patients (100) who died with a histologic diagnosis of carcinoma of the prostate were evaluated for the cause of death. In 57% of these patients, the direct cause of death was prostate cancer. The remaining 43 patients, while dying with prostate cancer, did not die directly because of this malignancy. If prostate cancer is diagnosed, efforts should be made to cure it.
Document emailed within 1 workday
Related Documents
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420Perrin, P.; François, O.; Maquet, J.H.; Bringeon, G.; Duteil, P.; Devonec, M. 1991: Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate Presse Medicale 20(28): 1313-1319
Rahardjo, D.; Kamil, S.T.; Pakasi, L.S. 2000: Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 563-570
Amayo, A.; Obara, W. 2004: Serum prostate specific antigen levels in men with benign prostatic hyperplasia and cancer of prostate East African Medical Journal 81(1): 22-26
Patel, P.; Nayak, J.G.; Biljetina, Z.; Donnelly, B.; Trpkov, K. 2015: Prostate cancer after initial high-grade prostatic intraepithelial neoplasia and benign prostate biopsy Canadian Journal of Urology 22(6): 8056-8062
Sadoughi, F.; Ghaderzadeh, M. 2014: A hybrid particle swarm and neural network approach for detection of prostate cancer from benign hyperplasia of prostate Studies in Health Technology and Informatics 205: 481-485
Feng, W.; Zhang, H.-b.; Wang, Y.-m.; Hu, J.-l. 2015: Correlation of FOXA1 with the malignancy and progression of prostate cancer Zhonghua Nan Ke Xue 21(5): 414-419
Voigt, K.D.; Bartsch, W. 1987: The role of tissue steroids in benign hyperplasia and prostate cancer Der Urologe. Ausg. a 26(6): 349-357
Armenian, H.K.; Lilienfeld, A.M.; Diamond, E.L.; Bross, I.D. 1974: Relation between benign prostatic hyperplasia and cancer of the prostate. A prospective and retrospective study Lancet 2(7873): 115-117
Kato, Y.; Nakata, S.; Sato, J.; Mayuzumi, T.; Shimizu, T. 1996: A case of prostate cancer diagnosed one and half year after retropubic prostatectomy for benign prostatic hypertrophy Hinyokika Kiyo. Acta Urologica Japonica 42(11): 907-909
Xiang, S.-T.; Zhou, S.-W.; Guan, W.; Wang, Q.-Z.; Zhang, B.; Liu, J.-H.; Ye, Z.-Q. 2003: Tumor infiltrating dendritic cells and Mucin1 gene expression in benign prostatic hyperplasia and prostate cancer Zhonghua Nan Ke Xue 9(7): 497-500
Hu, W.L.; Li, Y.Q.; He, H.X.; Li, Q.R.; Tian, Y.; Lai, R.Q.; Mei, H. 2000: KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese Asian Journal of Andrology 2(3): 221-224
Qiu, M-xing.; Wang, D.; Wu, H-min.; Xiong, G-bing.; Chen, Z-xiang. 2007: Dissection of prostate coalesce in treatment of benign prostate hypertrophy with relatively small volume Zhonghua Yi Xue Za Zhi 87(26): 1852-1853
Martin, A.A.; Clejan, S. 1994: Prostate specific antigen density: a method for differentiating prostate carcinoma from benign prostatic hypertrophy demonstrates ethnic variation Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 146(4): 163-171
Bauer, J.J.; Heidenberg, H.B. 1997: Immediate radical prostatectomy for incidentally found prostate cancer after open prostatectomy for benign prostatic hyperplasia Techniques in Urology 3(3): 172-175
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747